Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

20. Januar 2015 08:07 ET | Quelle: DiaMedica Inc.

DiaMedica Announces Resignation of Mark Robbins, as Executive Vice President

MINNEAPOLIS, MINNESOTA--(Marketwired - Jan. 20, 2015) - DiaMedica Inc. (TSX VENTURE:DMA) announced today that Mark Robbins has resigned his position with the Company to pursue other...
15. Januar 2015 08:02 ET | Quelle: DiaMedica Inc.

DiaMedica Appoints David Gurvey as Vice President of Finance

MINNEAPOLIS, MINNESOTA--(Marketwired - Jan. 15, 2015) - DiaMedica Inc. (TSX VENTURE:DMA) today announced the appointment of Mr. David Gurvey as the Company's Vice President of Finance....
09. Dezember 2014 18:30 ET | Quelle: DiaMedica Inc.

DiaMedica Announces Restructuring

MINNEAPOLIS, MINNESOTA--(Marketwired - Dec. 9, 2014) - DiaMedica Inc. (TSX VENTURE:DMA) today announced a company-wide restructuring aimed at preserving cash, reducing operating costs and...
17. November 2014 08:00 ET | Quelle: DiaMedica Inc.

DiaMedica Announces Top-line Results of Phase IIa Clinical Trial of DM199 for Type 2 Diabetes

MINNEAPOLIS, MINNESOTA--(Marketwired - Nov. 17, 2014) - DiaMedica Inc. (TSX VENTURE:DMA) today announced top-line results of its Phase IIa proof of concept clinical trial of DM199 in...
05. November 2014 20:28 ET | Quelle: DiaMedica Inc.

DiaMedica Cancels Proposed Financing

MINNEAPOLIS, MINNESOTA--(Marketwired - Nov. 5, 2014) - NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES DiaMedica Inc....
22. Oktober 2014 15:13 ET | Quelle: DiaMedica Inc.

DiaMedica Inc. Announces Public Offering

MINNEAPOLIS, MINNESOTA--(Marketwired - Oct. 22, 2014) - NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES DiaMedica Inc....
07. August 2014 08:00 ET | Quelle: DiaMedica Inc.

DiaMedica Publishes Manuscript Summarizing Preclinical Data on DM199 Treatment for Type 2 Diabetes

MINNEAPOLIS, MINNESOTA--(Marketwired - Aug. 7, 2014) - DiaMedica Inc. (TSX VENTURE:DMA), a clinical stage biopharmaceutical company primarily focused on the development of novel, first-in-class...
30. Juli 2014 08:00 ET | Quelle: DiaMedica Inc.

DiaMedica to Present at InvestMNt Conference on August 6, 2014

MINNEAPOLIS, MINNESOTA--(Marketwired - July 30, 2014) - DiaMedica Inc. (TSX VENTURE:DMA), a clinical stage biopharmaceutical company primarily focused on the development of novel,...
25. Juli 2014 16:30 ET | Quelle: DiaMedica Inc.

DiaMedica Inc. Announces Results of Annual General and Special Meeting of Shareholders

MINNEAPOLIS, MINNESOTA--(Marketwired - July 25, 2014) - DiaMedica Inc. (TSX VENTURE:DMA), a clinical stage biopharmaceutical company primarily focused on the development of novel,...
10. Juli 2014 08:30 ET | Quelle: DiaMedica Inc.

DiaMedica Promotes Mark Robbins to Executive Vice President

MINNEAPOLIS, MINNESOTA--(Marketwired - July 10, 2014) - DiaMedica Inc. (TSX VENTURE:DMA), a clinical stage biopharmaceutical company focused on the treatment of diabetes and its...

Vorherige Seite

Nächste Seite